• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume9, Issue4

EXPRESSION OF P53 IN UROTHELIAL CARCINOMA AND ITS CORRELATION WITH THE GRADE OF THE TUMOR – A TWO YEARS STUDY IN A TERTIARY HOSPITAL

    Dr Mothkoori Swetha, Dr P.V.Ramana, Dr. Bhanupriya Kakarala, Dr. T. Sundari Devi

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 439-451

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

BACKGROUND
In India Urothelial carcinoma of bladder  constitutes about 7% of all male cancers. It is associated with high morbidity and mortality.Current grading system in application by WHO/ISUP divides Urothelial malignancies as  low and high grade tumors by morphological criteria. Grading Urothelial carcinomas depending on morphological criteria alone is some times difficult in limited tissue. In such cases tumor grading by alternative  methods like IHC expression is useful. In the present study we have evaluated the diagnostic utility of p53  in grading Urothelial carcinomas.
MATERIALS AND METHODS :
The present study is an observational study conducted at department of Pathology, Gandhi Medical College/Hospital, Secunderabad for over a period of two years from June 2016 to May 2018. A total of 30 TURBT  and  Cystectomy specimens diagnosed as Urothelial carcinoma on routine H&E were included in the study. These tissues were later subjected to IHC markers for  p53. The slides are reviewed and expression of these markers was evaluated and  correlated with grade. The results were statistically analyzed.
Keywords:
    Urothelial carcinoma WHO/ISUP grading P53 Immunohistochemistry
  • PDF (1234 K)
  • XML
(2022). EXPRESSION OF P53 IN UROTHELIAL CARCINOMA AND ITS CORRELATION WITH THE GRADE OF THE TUMOR – A TWO YEARS STUDY IN A TERTIARY HOSPITAL. European Journal of Molecular & Clinical Medicine, 9(4), 439-451.
Dr Mothkoori Swetha, Dr P.V.Ramana, Dr. Bhanupriya Kakarala, Dr. T. Sundari Devi. "EXPRESSION OF P53 IN UROTHELIAL CARCINOMA AND ITS CORRELATION WITH THE GRADE OF THE TUMOR – A TWO YEARS STUDY IN A TERTIARY HOSPITAL". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 439-451.
(2022). 'EXPRESSION OF P53 IN UROTHELIAL CARCINOMA AND ITS CORRELATION WITH THE GRADE OF THE TUMOR – A TWO YEARS STUDY IN A TERTIARY HOSPITAL', European Journal of Molecular & Clinical Medicine, 9(4), pp. 439-451.
EXPRESSION OF P53 IN UROTHELIAL CARCINOMA AND ITS CORRELATION WITH THE GRADE OF THE TUMOR – A TWO YEARS STUDY IN A TERTIARY HOSPITAL. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 439-451.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 80
  • PDF Download: 163
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus